Treatment of Diarrhea with Antibiotics

Introduction to Antibiotic Therapy

The decision to use antibiotics should follow a targeted approach for severe or complicated infections, such as necrotizing fasciitis, severe intra-abdominal infections, or healthcare-associated infections, as recommended by the Infectious Diseases Society of America 1
Antibiotics should only be used in specific circumstances, including severe or prolonged symptoms, systemic signs of infection, immunocompromised patients, elderly patients with significant comorbidities, confirmed bacterial pathogens that warrant treatment, and dysentery (bloody diarrhea), as recommended by the Infectious Diseases Society of America and the American College of Physicians 1, 2, 3

For Campylobacter, azithromycin is the first choice, or ciprofloxacin alone can be used, as suggested by the Infectious Diseases Society of America 1
For Shigella, azithromycin, ciprofloxacin, or ceftriaxone alone can be used, according to the Infectious Diseases Society of America 1
For Salmonella, treatment is usually not necessary unless in high-risk patients, as recommended by the Infectious Diseases Society of America 1
For C. difficile, metronidazole alone is recommended for non-severe cases, with a strength of evidence rated as high by the Infectious Diseases Society of America 4
The Infectious Diseases Society of America guidelines recommend the following antimicrobial agents by pathogen:

Ciprofloxacin covers enteric gram-negative aerobic and facultative bacilli, and should be administered at 500 mg twice daily for 3-5 days 5, 2, 3
Metronidazole covers obligate anaerobic bacteria, particularly B. fragilis, and should be administered at 500 mg three times daily for 7-10 days, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 5, 4
The combination of ciprofloxacin and metronidazole should be reserved for intra-abdominal infections requiring coverage of both aerobic gram-negative and anaerobic bacteria, biliary infections of severe physiologic disturbance, or healthcare-associated infections 2

Alternative regimens for mild-to-moderate infections include amoxicillin-clavulanic acid or ceftriaxone/cefotaxime plus metronidazole, and for severe infections, piperacillin-tazobactam or meropenem can be used 6
Fluoroquinolone resistance is increasing among Enterobacteriaceae, and quinolones should not be used unless hospital surveys indicate >90% susceptibility of E. coli 7, 2
Local E. coli resistance to fluoroquinolones should be monitored, and alternative regimens considered if resistance rates exceed 10-20% 2, 3
In areas with high fluoroquinolone resistance (>20%), such as parts of Asia (China, India, Thailand, Vietnam), fluoroquinolones are not recommended as first-line therapy 8

Clinical response (resolution of fever, diarrhea, abdominal pain) and adverse effects (C. difficile infection, drug toxicity) should be assessed daily 2
Consider cultures from the infection site for patients with prior antibiotic exposure or at high risk for resistant organisms 2
Treatment duration for most intra-abdominal infections is 7-14 days, but can be shorter with adequate source control and clinical improvement 2
Sequential IV-to-oral therapy is recommended when patients show clinical improvement and can tolerate oral intake 2

Ciprofloxacin carries a risk of tendonitis and tendon rupture with prolonged use, as warned by the European Medicines Agency 9
Metronidazole carries a risk of peripheral neuropathy with extended use, and patients should be advised to stop if numbness or tingling develops in extremities, as cautioned by the European Medicines Agency 9